Neutral impactIPO
Manipal Health IPO: Check latest GMP, day 2 subscription status, and other details - Should you apply or skip?
livemint.com 5 hrs ago·30 Jul 2026, 3:14 am
IPO livemint.com
The IPO for Manipal Health Enterprises has opened for subscription on the second day. This public issue allows the company to raise capital to reduce its debt and fund future growth. The listing is expected to take place in the coming weeks, and the stock price will be determined on the basis of the final subscription figures and market demand.
For investors, the key takeaway is the gap between the current market price and the issue price. This difference, known as the Grey Market Premium (GMP), indicates the sentiment around the listing. A high GMP suggests strong demand, while a low or negative one may point to a lukewarm reception. Investors should review the company's financial health and the valuation before making a decision.
Moving forward, the focus will be on the final subscription numbers and the grey market trend. A strong response in the last two days could boost the stock price on listing. However, investors should be cautious and avoid chasing the stock based solely on market hype. A thorough review of the prospectus is essential to understand the risks involved.
Key takeaways
- Category: IPO.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
